lactobionic acid has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Anfuso, CD; Cristaldi, M; Gagliano, C; Genovese, C; Lupo, G; Olivieri, M; Pezzino, S; Rusciano, D | 1 |
Elias, PM; Fujiwara, S; Hatano, Y; Jeong, SK; Matsuda-Hirose, H; Sakai, T; Takahashi, D; Zhang, W | 1 |
3 other study(ies) available for lactobionic acid and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease.
Topics: Animals; Cell Count; Cell Line; Cornea; Corneal Diseases; Disaccharides; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Rabbits; Wound Healing | 2018 |
Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis.
Topics: Animals; Dermatitis, Atopic; Disaccharides; Disease Models, Animal; Drug Therapy, Combination; Epidermis; Immunoglobulins; Mice; Mice, Inbred Strains; Oxazolone; Random Allocation; Receptor, PAR-2; Receptors, Cytokine; Treatment Outcome | 2016 |